15.01.2013 Views

The Mitochondrial Free Radical Theory of Aging - Supernova: Pliki

The Mitochondrial Free Radical Theory of Aging - Supernova: Pliki

The Mitochondrial Free Radical Theory of Aging - Supernova: Pliki

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

History <strong>of</strong> the <strong>Mitochondrial</strong> <strong>Free</strong> <strong>Radical</strong> <strong>The</strong>ory <strong>of</strong> <strong>Aging</strong>, 1954-1995<br />

This is something <strong>of</strong> a paradox, since we know (from the rarity <strong>of</strong> fibers with reduced<br />

but non-zero OXPHOS function—see Section 6.6) that the selective advantage <strong>of</strong> mutant<br />

molecules is very great. One might therefore predict that these 4% <strong>of</strong> fibers with low levels<br />

<strong>of</strong> mutant mtDNA would become completely OXPHOS-deficient within months, whereas<br />

in fact even very elderly individuals never exhibit such levels.<br />

<strong>The</strong> answer explains the title <strong>of</strong> this section. When a mtDNA mutation first occurs, it<br />

probably has no impact whatever on its host mitochondrion’s function, because that<br />

mitochondrion also possesses several wild-type genomes. Accordingly it is a matter <strong>of</strong> pure<br />

chance, unbiased by any selective pressure, whether that mitochondrion divides (and its<br />

mtDNA is replicated) or is destroyed by lysosomal digestion (see Section 2.4.6). If it does<br />

divide, then it is again a matter <strong>of</strong> chance whether the two copies <strong>of</strong> the mutant molecule<br />

segregate into the same daughter mitochondrion or one into each. Cumulatively, therefore,<br />

the chance that a given spontaneous mutation will end up homozygous in some<br />

mitochondrion is rather low, since it involves several mitochondrial divisions going the<br />

right way. It is probably not until then that the mutation will have any significant effect on<br />

its host mitochondrion’s OXPHOS functionality. In fact, that functionality is likely to be<br />

largely retained for a couple <strong>of</strong> mitochondrial generations even after homozygosity is<br />

achieved, since some <strong>of</strong> the host mitochondrion’s membrane proteins are inherited from<br />

previous generations when it still had some wild-type genomes.<br />

This means that, on average, a given mutation must have survived for a considerable<br />

while by pure luck in order to exert a phenotypic effect, and thus in order to begin enjoying<br />

a selective advantage. Most mutations will be snuffed out (by chance, not by any selective<br />

pressure) before this. But many <strong>of</strong> those that are snuffed out will progress part <strong>of</strong> this way,<br />

being randomly replicated up to five or ten copies. And that sort <strong>of</strong> level, among a total <strong>of</strong><br />

perhaps 10 4 or 10 5 molecules total in a sample, is enough to be detected by PCR. This means<br />

that the high proportion <strong>of</strong> fibers which harbour detectable levels <strong>of</strong> mutations are not a<br />

paradox after all: most <strong>of</strong> those mutations were not destined to take over their cellular<br />

environment anyway.<br />

6.6.3. Cybrids<br />

An in vitro technology was developed in the 1980s 68,69 which has had a dramatic impact<br />

on, among other things, the study <strong>of</strong> selective advantage <strong>of</strong> mtDNA species. King and Attardi<br />

developed a method for removing all the mtDNA in a human cell culture and yet keeping<br />

the culture alive. A summary <strong>of</strong> the technique appears in Section 9.2; its relevance to this<br />

chapter is in how these cells (termed ρ 0 cells) have been used to study mtDNA selection. <strong>The</strong><br />

value <strong>of</strong> ρ 0 cells is that one can repopulate them with mitochondria <strong>of</strong> one’s choice. Thus,<br />

for example, if one has a patient suffering from a mtDNA-linked disease, whose cells contain<br />

some mutant mtDNA and some wild-type, then one can take platelets 70 (which have<br />

mitochondria but no nucleus), or other cells whose nucleus has been artificially removed,<br />

and fuse them with ρ 0 cells. <strong>The</strong> resulting fusion cells are called cytoplasmic hybrids, usually<br />

contracted to cybrids. <strong>The</strong>n one can follow the relative abundance <strong>of</strong> two species <strong>of</strong> mtDNA<br />

in a culture <strong>of</strong> these fused cells; and, crucially, one can repeat the experiment with a different<br />

source <strong>of</strong> mtDNA, from a different patient, but with the same ρ 0 line, thereby eliminating<br />

complications <strong>of</strong> interpretation due to differing nuclear genotypes. It was quickly<br />

demonstrated 71 that the mutant mtDNA genotype <strong>of</strong> a well-studied mutation <strong>of</strong>ten took<br />

over such cultures.<br />

Unfortunately, since then the picture has become altogether muddier. A study 72 which<br />

essentially repeated this experiment found that some such cultures behaved as reported, 71<br />

but others exhibited the opposite behaviour—mitochondria <strong>of</strong> the mutant genotype<br />

dwindled in number. Moreover, multiple cultures created from the same recipient (ρ 0 ) cell<br />

77

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!